Trends of generic substitution in community pharmacies

被引:38
作者
Suh, DC [1 ]
机构
[1] Rutgers State Univ, Coll Pharm, Piscataway, NJ 08854 USA
来源
PHARMACY WORLD & SCIENCE | 1999年 / 21卷 / 06期
关键词
brand name drugs; drug formulary; generic substitution; physician allowance; pharmacist substitution; pharmacy practice;
D O I
10.1023/A:1008781619011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study is to measure the rate of generic drug substitution by pharmacists, and factors influencing generic substitution, such as the extent of drugs listed on the formulary as well as physicians' and patients' acceptance rate of generic substitutes. A total of 9,328 prescription orders were retrospectively reviewed from 94 pharmacies which were selected at random. The substitution rate by pharmacists, which is the rate using the number of prescriptions eligible for substitution as the denominator, has risen from 47% in 1979 to 96% in 1997; double the rate over the past 20 years. The net substitution rate, which uses all prescriptions as the denominator, was 30% in 1997; over 4 times greater than the rate in 1979. Physicians wrote most prescriptions (86%) using the brand name of the drug, which has been the trend for the past 20 years. Of the prescriptions ordered by brand name, 47% were substitutable according to the New Jersey formulary. Of these prescriptions, prescribers allowed generic substitution 77% of the time. Out of these prescriptions, 97% of patients agreed to use a generic substitute if the physician approved of substitution. Generic substitution rates have increased, probably due to greater acceptance of generics by physicians and pharmacists as well as encouragement from external sources such as third party payers. Health care professionals, third parties, and patients all have an important role to play in order to increase the use of generics, and therefore reduce drug expenditures.
引用
收藏
页码:260 / 265
页数:6
相关论文
共 30 条
[1]   SUBSTITUTION LAWS, INSURANCE-COVERAGE, AND GENERIC DRUG-USE [J].
ANIS, AH .
MEDICAL CARE, 1994, 32 (03) :240-256
[2]  
[Anonymous], 1989, SAS STAT US GUID VER
[3]   A physician survey on generic drugs and substitution or critical dose medications [J].
Banahan, BF ;
Kolassa, EM .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (18) :2080-2088
[4]  
BEAVERS N, 1997, DRUG TOPICS S, pS8
[5]   COST AND PRICE OF COMPARABLE BRANDED AND GENERIC PHARMACEUTICALS [J].
BLOOM, BS ;
WIERZ, DJ ;
PAULY, MV .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (18) :2523-2530
[6]  
BURTON T, 1986, GENERIC DRUG LAWS DE
[7]  
Carroll N V, 1995, Am Pharm, VNS35, P27
[8]  
CARROLL NV, 1987, AKRON BUS ECON REV, V18, P11
[9]  
CULIN TT, 1989, AM PHARM, V29, P25
[10]  
*DRUG UT REV COUNC, 1999, NEW JERS GEN FORM LI